{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:53:24Z","timestamp":1792612404503,"version":"4.5.0"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1038\/s41584-021-00683-2","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T14:10:19Z","timestamp":1630678219000},"page":"596-607","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":109,"title":["Advances in epigenetics in systemic sclerosis: molecular mechanisms and therapeutic potential"],"prefix":"10.1038","volume":"17","author":[{"given":"Pei-Suen","family":"Tsou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3416-7330","authenticated-orcid":false,"given":"Steven","family":"O\u2019Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,3]]},"reference":[{"key":"683_CR1","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton, C. P. & Khanna, D. Systemic sclerosis. Lancet 390, 1685\u20131699 (2017).","journal-title":"Lancet"},{"key":"683_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s11926-020-00918-3","volume":"22","author":"M Hinchcliff","year":"2020","unstructured":"Hinchcliff, M. & O\u2019Reilly, S. Current and potential new targets in systemic sclerosis therapy: a new hope. Curr. Rheumatol. Rep. 22, 42 (2020).","journal-title":"Curr. Rheumatol. Rep."},{"key":"683_CR3","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.semarthrit.2011.10.004","volume":"41","author":"CP Sime\u00f3n-Aznar","year":"2012","unstructured":"Sime\u00f3n-Aznar, C. P. et al. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status. Semin. Arthritis Rheum. 41, 789\u2013800 (2012).","journal-title":"Semin. Arthritis Rheum."},{"key":"683_CR4","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1136\/ard.2008.091710","volume":"68","author":"MC Vonk","year":"2009","unstructured":"Vonk, M. C. et al. Systemic sclerosis and its pulmonary complications in The Netherlands: an epidemiological study. Ann. Rheum. Dis. 68, 961\u2013965 (2009).","journal-title":"Ann. Rheum. Dis."},{"key":"683_CR5","doi-asserted-by":"publisher","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","volume":"1","author":"Y Allanore","year":"2015","unstructured":"Allanore, Y. et al. Systemic sclerosis. Nat. Rev. Dis. Primers 1, 15002 (2015).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"683_CR6","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1172\/JCI31139","volume":"117","author":"J Varga","year":"2007","unstructured":"Varga, J. & Abraham, D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J. Clin. Invest. 117, 557\u2013567 (2007).","journal-title":"J. Clin. Invest."},{"key":"683_CR7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jaut.2013.01.012","volume":"41","author":"Y Luo","year":"2013","unstructured":"Luo, Y., Wang, Y., Wang, Q., Xiao, R. & Lu, Q. Systemic sclerosis: genetics and epigenetics. J. Autoimmun. 41, 161\u2013167 (2013).","journal-title":"J. Autoimmun."},{"key":"683_CR8","first-page":"1481","volume":"32","author":"DD Gladman","year":"2005","unstructured":"Gladman, D. D. et al. HLA markers for susceptibility and expression in scleroderma. J. Rheumatol. 32, 1481 (2005).","journal-title":"J. Rheumatol."},{"key":"683_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/rheumatology\/ker335","volume":"51","author":"L Beretta","year":"2012","unstructured":"Beretta, L. et al. Analysis of Class II human leucocyte antigens in Italian and Spanish systemic sclerosis. Rheumatology 51, 52\u201359 (2012).","journal-title":"Rheumatology"},{"key":"683_CR10","doi-asserted-by":"publisher","first-page":"3900","DOI":"10.1093\/rheumatology\/keaa446","volume":"59","author":"S Patel","year":"2020","unstructured":"Patel, S. et al. Occupational silica exposure in an Australian systemic sclerosis cohort. Rheumatology 59, 3900\u20133905 (2020).","journal-title":"Rheumatology"},{"key":"683_CR11","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1126\/science.1156995","volume":"320","author":"C Dostert","year":"2008","unstructured":"Dostert, C. et al. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320, 674 (2008).","journal-title":"Science"},{"key":"683_CR12","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","volume":"128","author":"T Kouzarides","year":"2007","unstructured":"Kouzarides, T. Chromatin modifications and their function. Cell 128, 693\u2013705 (2007).","journal-title":"Cell"},{"key":"683_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrg.2017.80","volume":"19","author":"F Lyko","year":"2018","unstructured":"Lyko, F. The DNA methyltransferase family: a versatile toolkit for epigenetic regulation. Nat. Rev. Genet. 19, 81\u201392 (2018).","journal-title":"Nat. Rev. Genet."},{"key":"683_CR14","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1126\/science.1147939","volume":"317","author":"M Bostick","year":"2007","unstructured":"Bostick, M. et al. UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science 317, 1760\u20131764 (2007).","journal-title":"Science"},{"key":"683_CR15","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1126\/science.1170116","volume":"324","author":"M Tahiliani","year":"2009","unstructured":"Tahiliani, M. et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930\u2013935 (2009).","journal-title":"Science"},{"key":"683_CR16","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1126\/science.1210944","volume":"333","author":"YF He","year":"2011","unstructured":"He, Y. F. et al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333, 1303\u20131307 (2011).","journal-title":"Science"},{"key":"683_CR17","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.cell.2013.04.002","volume":"153","author":"L Shen","year":"2013","unstructured":"Shen, L. et al. Genome-wide analysis reveals TET- and TDG-dependent 5-methylcytosine oxidation dynamics. Cell 153, 692\u2013706 (2013).","journal-title":"Cell"},{"key":"683_CR18","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.15252\/embj.201488290","volume":"33","author":"B Delatte","year":"2014","unstructured":"Delatte, B., Deplus, R. & Fuks, F. Playing TETris with DNA modifications. EMBO J. 33, 1198\u20131211 (2014).","journal-title":"EMBO J."},{"key":"683_CR19","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1172\/JCI122462","volume":"130","author":"C Dees","year":"2020","unstructured":"Dees, C. et al. TGF-\u03b2\u2013induced epigenetic deregulation of SOCS3 facilitates STAT3 signaling to promote fibrosis. J. Clin. Invest. 130, 2347\u20132363 (2020).","journal-title":"J. Clin. Invest."},{"key":"683_CR20","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.molmed.2019.02.001","volume":"25","author":"J Henderson","year":"2019","unstructured":"Henderson, J., Distler, J. & O\u2019Reilly, S. The role of epigenetic modifications in systemic sclerosis: a druggable target. Trends Mol. Med. 25, 395\u2013411 (2019).","journal-title":"Trends Mol. Med."},{"key":"683_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281\u2013297 (2004).","journal-title":"Cell"},{"key":"683_CR22","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1042\/CS20170039","volume":"131","author":"S Horsburgh","year":"2017","unstructured":"Horsburgh, S. et al. MicroRNAs in the skin: role in development, homoeostasis and regeneration. Clin. Sci. 131, 1923\u20131940 (2017).","journal-title":"Clin. Sci."},{"key":"683_CR23","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1101\/gad.1706508","volume":"22","author":"F Ozsolak","year":"2008","unstructured":"Ozsolak, F. et al. Chromatin structure analyses identify miRNA promoters. Genes Dev. 22, 3172\u20133183 (2008).","journal-title":"Genes Dev."},{"key":"683_CR24","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.cell.2006.03.043","volume":"125","author":"J Han","year":"2006","unstructured":"Han, J. et al. Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell 125, 887\u2013901 (2006).","journal-title":"Cell"},{"key":"683_CR25","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature03049","volume":"432","author":"AM Denli","year":"2004","unstructured":"Denli, A. M., Tops, B. B., Plasterk, R. H., Ketting, R. F. & Hannon, G. J. Processing of primary microRNAs by the microprocessor complex. Nature 432, 231\u2013235 (2004).","journal-title":"Nature"},{"key":"683_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1126\/science.1090599","volume":"303","author":"E Lund","year":"2004","unstructured":"Lund, E., G\u00fcttinger, S., Calado, A., Dahlberg, J. E. & Kutay, U. Nuclear export of microRNA precursors. Science 303, 95 (2004).","journal-title":"Science"},{"key":"683_CR27","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1126\/science.1062961","volume":"293","author":"G Hutv\u00e1gner","year":"2001","unstructured":"Hutv\u00e1gner, G. et al. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293, 834 (2001).","journal-title":"Science"},{"key":"683_CR28","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41576-018-0017-y","volume":"19","author":"B Uszczynska-Ratajczak","year":"2018","unstructured":"Uszczynska-Ratajczak, B., Lagarde, J., Frankish, A., Guig\u00f3, R. & Johnson, R. Towards a complete map of the human long non-coding RNA transcriptome. Nat. Rev. Genet. 19, 535\u2013548 (2018).","journal-title":"Nat. Rev. Genet."},{"key":"683_CR29","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/cr.2014.35","volume":"24","author":"JF Xiang","year":"2014","unstructured":"Xiang, J. F. et al. Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus. Cell Res. 24, 513\u2013531 (2014).","journal-title":"Cell Res."},{"key":"683_CR30","doi-asserted-by":"publisher","first-page":"12181","DOI":"10.1007\/s13277-014-2526-4","volume":"35","author":"X He","year":"2014","unstructured":"He, X. et al. C-Myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion. Tumour Biol. 35, 12181\u201312188 (2014).","journal-title":"Tumour Biol."},{"key":"683_CR31","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1126\/science.1163045","volume":"322","author":"J Zhao","year":"2008","unstructured":"Zhao, J., Sun, B. K., Erwin, J. A., Song, J. J. & Lee, J. T. Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science 322, 750\u2013756 (2008).","journal-title":"Science"},{"key":"683_CR32","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.celrep.2015.03.043","volume":"11","author":"VB O\u2019Leary","year":"2015","unstructured":"O\u2019Leary, V. B. et al. PARTICLE, a triplex-forming long ncRNA, regulates locus-specific methylation in response to low-dose irradiation. Cell Rep. 11, 474\u2013485 (2015).","journal-title":"Cell Rep."},{"key":"683_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8743","volume":"6","author":"T Mondal","year":"2015","unstructured":"Mondal, T. et al. MEG3 long noncoding RNA regulates the TGF-\u03b2 pathway genes through formation of RNA-DNA triplex structures. Nat. Commun. 6, 7743 (2015).","journal-title":"Nat. Commun."},{"key":"683_CR34","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nrg.2016.20","volume":"17","author":"DW Thomson","year":"2016","unstructured":"Thomson, D. W. & Dinger, M. E. Endogenous microRNA sponges: evidence and controversy. Nat. Rev. Genet. 17, 272\u2013283 (2016).","journal-title":"Nat. Rev. Genet."},{"key":"683_CR35","doi-asserted-by":"publisher","DOI":"10.1126\/science.aam8526","volume":"357","author":"M Piwecka","year":"2017","unstructured":"Piwecka, M. et al. Loss of a mammalian circular RNA locus causes miRNA deregulation and affects brain function. Science 357, eaam8526 (2017).","journal-title":"Science"},{"key":"683_CR36","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nrm3382","volume":"13","author":"K Luger","year":"2012","unstructured":"Luger, K., Dechassa, M. L. & Tremethick, D. J. New insights into nucleosome and chromatin structure: an ordered state or a disordered affair? Nat. Rev. Mol. Cell Biol. 13, 436\u2013447 (2012).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"683_CR37","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nrm3890","volume":"15","author":"P Tessarz","year":"2014","unstructured":"Tessarz, P. & Kouzarides, T. Histone core modifications regulating nucleosome structure and dynamics. Nat. Rev. Mol. Cell Biol. 15, 703\u2013708 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"683_CR38","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang, D. et al. Metabolic regulation of gene expression by histone lactylation. Nature 574, 575\u2013580 (2019).","journal-title":"Nature"},{"key":"683_CR39","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1126\/science.1101400","volume":"306","author":"Y Wang","year":"2004","unstructured":"Wang, Y. et al. Human PAD4 regulates histone arginine methylation levels via demethylimination. Science 306, 279\u2013283 (2004).","journal-title":"Science"},{"key":"683_CR40","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.cell.2004.12.012","volume":"119","author":"Y Shi","year":"2004","unstructured":"Shi, Y. et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119, 941\u2013953 (2004).","journal-title":"Cell"},{"key":"683_CR41","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/nature04433","volume":"439","author":"Y Tsukada","year":"2006","unstructured":"Tsukada, Y. et al. Histone demethylation by a family of JmjC domain-containing proteins. Nature 439, 811\u2013816 (2006).","journal-title":"Nature"},{"key":"683_CR42","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11926-017-0630-3","volume":"19","author":"C Dowson","year":"2017","unstructured":"Dowson, C., Simpson, N., Duffy, L. & O\u2019Reilly, S. Innate immunity in systemic sclerosis. Curr. Rheumatol. Rep. 19, 2 (2017).","journal-title":"Curr. Rheumatol. Rep."},{"key":"683_CR43","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1080\/03009740902758875","volume":"38","author":"W Lei","year":"2009","unstructured":"Lei, W. et al. Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand. J. Rheumatol. 38, 369\u2013374 (2009).","journal-title":"Scand. J. Rheumatol."},{"key":"683_CR44","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1002\/art.34376","volume":"64","author":"X Lian","year":"2012","unstructured":"Lian, X. et al. DNA demethylation of CD40L in CD4+ T cells from women with systemic sclerosis: A possible explanation for female susceptibility. Arthritis Rheum. 64, 2338\u20132345 (2012).","journal-title":"Arthritis Rheum."},{"key":"683_CR45","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","volume":"229","author":"R Elgueta","year":"2009","unstructured":"Elgueta, R. et al. Molecular mechanism and function of CD40\/CD40L engagement in the immune system. Immunol. Rev. 229, 152\u2013172 (2009).","journal-title":"Immunol. Rev."},{"key":"683_CR46","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.clim.2012.01.005","volume":"143","author":"H Jiang","year":"2012","unstructured":"Jiang, H. et al. Demethylation of TNFSF7 contributes to CD70 overexpression in CD4+ T cells from patients with systemic sclerosis. Clin. Immunol. 143, 39\u201344 (2012).","journal-title":"Clin. Immunol."},{"key":"683_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/1868-7083-6-25","volume":"6","author":"Y Wang","year":"2014","unstructured":"Wang, Y. et al. Hypomethylation and overexpression of ITGAL (CD11a) in CD4+ T cells in systemic sclerosis. Clin. Epigenetics 6, 25 (2014).","journal-title":"Clin. Epigenetics"},{"key":"683_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-019-0602-8","volume":"12","author":"T Lu","year":"2019","unstructured":"Lu, T. et al. Whole-genome bisulfite sequencing in systemic sclerosis provides novel targets to understand disease pathogenesis. BMC Med. Genomics 12, 144 (2019).","journal-title":"BMC Med. Genomics"},{"key":"683_CR49","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1002\/art.34424","volume":"64","author":"J Wei","year":"2012","unstructured":"Wei, J. et al. Wnt\/\u03b2-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells. Arthritis Rheum. 64, 2734\u20132745 (2012).","journal-title":"Arthritis Rheum."},{"key":"683_CR50","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.jid.2017.12.003","volume":"138","author":"W Ding","year":"2018","unstructured":"Ding, W. et al. Genome-wide DNA methylation analysis in systemic sclerosis reveals hypomethylation of IFN-associated genes in CD4+ and CD8+ T cells. J. Invest. Dermatol. 138, 1069\u20131077 (2018).","journal-title":"J. Invest. Dermatol."},{"key":"683_CR51","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13073-020-00779-6","volume":"12","author":"T Li","year":"2020","unstructured":"Li, T. et al. Epigenomics and transcriptomics of systemic sclerosis CD4+ T cells reveal long-range dysregulation of key inflammatory pathways mediated by disease-associated susceptibility loci. Genome Med. 12, 81 (2020).","journal-title":"Genome Med."},{"key":"683_CR52","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1038\/s41375-020-0906-x","volume":"34","author":"Y Qiu","year":"2020","unstructured":"Qiu, Y. & Huang, S. CTCF-mediated genome organization and leukemogenesis. Leukemia 34, 2295\u20132304 (2020).","journal-title":"Leukemia"},{"key":"683_CR53","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00281-015-0503-7","volume":"37","author":"N Fullard","year":"2015","unstructured":"Fullard, N. & O\u2019Reilly, S. Role of innate immune system in systemic sclerosis. Semin. Immunopathol. 37, 511\u2013517 (2015).","journal-title":"Semin. Immunopathol."},{"key":"683_CR54","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1136\/annrheumdis-2018-214295","volume":"78","author":"M van der Kroef","year":"2019","unstructured":"van der Kroef, M. et al. Histone modifications underlie monocyte dysregulation in patients with systemic sclerosis, underlining the treatment potential of epigenetic targeting. Ann. Rheum. Dis. 78, 529\u2013538 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"683_CR55","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1002\/art.39602","volume":"68","author":"M Ciechomska","year":"2016","unstructured":"Ciechomska, M. et al. Histone demethylation and Toll-like receptor 8-dependent cross-talk in monocytes promotes transdifferentiation of fibroblasts in systemic sclerosis via Fra-2. Arthritis Rheumatol. 68, 1493\u20131504 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"683_CR56","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fimmu.2019.00100","volume":"10","author":"B Mariotti","year":"2019","unstructured":"Mariotti, B. et al. The long non-coding RNA NRIR drives IFN-response in monocytes: implication for systemic sclerosis. Front. Immunol. 10, 100 (2019).","journal-title":"Front. Immunol."},{"key":"683_CR57","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1002\/eji.201948428","volume":"50","author":"M Ciechomska","year":"2020","unstructured":"Ciechomska, M. et al. Global miRNA and mRNA expression profiles identify miRNA-26a-2-3p-dependent repression of IFN signature in systemic sclerosis human monocytes. Eur. J. Immunol. 50, 1057\u20131066 (2020).","journal-title":"Eur. J. Immunol."},{"key":"683_CR58","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1002\/art.40163","volume":"69","author":"M Rossato","year":"2017","unstructured":"Rossato, M. et al. Association of microRNA-618 expression with altered frequency and activation of plasmacytoid dendritic cells in patients with systemic sclerosis. Arthritis Rheumatol. 69, 1891\u20131902 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"683_CR59","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3390\/jcm10030491","volume":"10","author":"E Chouri","year":"2021","unstructured":"Chouri, E. et al. Implication of miR-126 and miR-139-5p in plasmacytoid dendritic cell dysregulation in systemic sclerosis. J. Clin. Med. 10, 491 (2021).","journal-title":"J. Clin. Med."},{"key":"683_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19702-z","volume":"11","author":"Q Liu","year":"2020","unstructured":"Liu, Q. et al. Chromatin accessibility landscapes of skin cells in systemic sclerosis nominate dendritic cells in disease pathogenesis. Nat. Commun. 11, 5843 (2020).","journal-title":"Nat. Commun."},{"key":"683_CR61","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/art.41536","volume":"73","author":"PS Tsou","year":"2021","unstructured":"Tsou, P. S., Palisoc, P. J., Flavahan, N. A. & Khanna, D. Dissecting the cellular mechanism of prostacyclin analogue iloprost in reversing vascular dysfunction in scleroderma. Arthritis Rheumatol. 73, 520\u2013529 (2021).","journal-title":"Arthritis Rheumatol."},{"key":"683_CR62","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1161\/CIRCRESAHA.111.242057","volume":"109","author":"M Manetti","year":"2011","unstructured":"Manetti, M. et al. Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis. Circ. Res. 109, e14\u2013e26 (2011).","journal-title":"Circ. Res."},{"key":"683_CR63","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1111\/jcmm.12105","volume":"17","author":"Y Wang","year":"2013","unstructured":"Wang, Y. & Kahaleh, B. Epigenetic repression of bone morphogenetic protein receptor II expression in scleroderma. J. Cell Mol. Med. 17, 1291\u20131299 (2013).","journal-title":"J. Cell Mol. Med."},{"key":"683_CR64","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1002\/art.39828","volume":"68","author":"PS Tsou","year":"2016","unstructured":"Tsou, P. S. et al. Histone deacetylase 5 is overexpressed in scleroderma endothelial cells and impairs angiogenesis via repression of proangiogenic factors. Arthritis Rheumatol. 68, 2975\u20132985 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"683_CR65","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.1073\/pnas.1813006116","volume":"116","author":"PS Tsou","year":"2019","unstructured":"Tsou, P. S. et al. Inhibition of EZH2 prevents fibrosis and restores normal angiogenesis in scleroderma. Proc. Natl Acad. Sci. USA 116, 3695\u20133702 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"683_CR66","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1002\/art.41694","volume":"73","author":"PS Tsou","year":"2021","unstructured":"Tsou, P. S., Palisoc, P. J., Ali, M., Khanna, D. & Sawalha, A. H. Genome-wide reduction in chromatin accessibility and unique transcription factor footprints in endothelial cells and fibroblasts in scleroderma skin. Arthritis Rheumatol. 73, 1501\u20131513 (2021).","journal-title":"Arthritis Rheumatol."},{"key":"683_CR67","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41584-019-0324-5","volume":"16","author":"B Hinz","year":"2020","unstructured":"Hinz, B. & Lagares, D. Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases. Nat. Rev. Rheumatol. 16, 11\u201331 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"683_CR68","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1136\/annrheumdis-2014-205303","volume":"74","author":"N Altorok","year":"2015","unstructured":"Altorok, N., Tsou, P. S., Coit, P., Khanna, D. & Sawalha, A. H. Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies. Ann. Rheum. Dis. 74, 1612\u20131620 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"683_CR69","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/genes12020129","volume":"12","author":"D Baker Frost","year":"2021","unstructured":"Baker Frost, D. et al. Differential DNA methylation landscape in skin fibroblasts from African americans with systemic sclerosis. Genes (Basel) 12, 129 (2021).","journal-title":"Genes (Basel)"},{"key":"683_CR70","doi-asserted-by":"publisher","first-page":"21825","DOI":"10.1002\/jcp.28032","volume":"234","author":"X-F Wang","year":"2019","unstructured":"Wang, X.-F., Zhang, B.-H., Lu, X.-Q. & Wang, R.-Q. DLX5 gene regulates the Notch signaling pathway to promote glomerulosclerosis and interstitial fibrosis in uremic rats. J. Cell. Physiol. 234, 21825\u201321837 (2019).","journal-title":"J. Cell. Physiol."},{"key":"683_CR71","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/rheumatology\/key327","volume":"58","author":"J Henderson","year":"2019","unstructured":"Henderson, J. et al. Methyl cap binding protein 2: a key epigenetic protein in systemic sclerosis. Rheumatology 58, 527\u2013535 (2019).","journal-title":"Rheumatology"},{"key":"683_CR72","first-page":"1208","volume":"77","author":"Y He","year":"2018","unstructured":"He, Y., Tsou, P. S., Khanna, D. & Sawalha, A. H. Methyl-CpG-binding protein 2 mediates antifibrotic effects in scleroderma fibroblasts. Ann. Rheum. Dis. 77, 1208\u20131218 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"683_CR73","volume":"7","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program. Sci. Adv. 7, eabb6075 (2021).","journal-title":"Sci. Adv."},{"key":"683_CR74","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.cytogfr.2012.04.003","volume":"23","author":"S O\u2019Reilly","year":"2012","unstructured":"O\u2019Reilly, S., Ciechomska, M., Cant, R., H\u00fcgle, T. & van Laar, J. M. Interleukin-6, its role in fibrosing conditions. Cytokine Growth Factor. Rev. 23, 99\u2013107 (2012).","journal-title":"Cytokine Growth Factor. Rev."},{"key":"683_CR75","doi-asserted-by":"publisher","first-page":"9952","DOI":"10.1074\/jbc.M113.545822","volume":"289","author":"S O\u2019Reilly","year":"2014","unstructured":"O\u2019Reilly, S., Ciechomska, M., Cant, R. & van Laar, J. M. Interleukin-6 (IL-6) trans signaling drives a STAT3-dependent pathway that leads to hyperactive transforming growth factor-\u03b2 (TGF-\u03b2) signaling promoting SMAD3 activation and fibrosis via Gremlin protein. J. Biol. Chem. 289, 9952\u20139960 (2014).","journal-title":"J. Biol. Chem."},{"key":"683_CR76","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw0790","volume":"11","author":"JY Shin","year":"2019","unstructured":"Shin, J. Y. et al. Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis. Sci. Transl. Med. 11, eaaw0790 (2019).","journal-title":"Sci. Transl. Med."},{"key":"683_CR77","doi-asserted-by":"crossref","unstructured":"Vichaikul, S. et al. Inhibition of histone readers bromodomain and extraterminal domain proteins alleviates scleroderma fibrosis. Arthritis Rheumatol. https:\/\/acrabstracts.org\/abstract\/inhibition-of-histone-readers-bromodomain-and-extraterminal-domain-proteins-alleviates-scleroderma-fibrosis\/ (2019).","DOI":"10.1101\/2020.08.07.242198"},{"key":"683_CR78","doi-asserted-by":"publisher","first-page":"1484736","DOI":"10.1155\/2019\/1484736","volume":"2019","author":"CJW Stock","year":"2019","unstructured":"Stock, C. J. W. et al. Bromodomain and extraterminal (BET) protein inhibition restores redox balance and inhibits myofibroblast activation. Biomed. Res. Int. 2019, 1484736 (2019).","journal-title":"Biomed. Res. Int."},{"key":"683_CR79","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.137127","volume":"5","author":"YY Sanders","year":"2020","unstructured":"Sanders, Y. Y. et al. Brd4-p300 inhibition downregulates Nox4 and accelerates lung fibrosis resolution in aged mice. JCI Insight 5, e137127 (2020).","journal-title":"JCI Insight"},{"key":"683_CR80","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1136\/annrheumdis-2019-216542","volume":"79","author":"CW Wasson","year":"2020","unstructured":"Wasson, C. W. et al. Long non-coding RNA HOTAIR drives EZH2-dependent myofibroblast activation in systemic sclerosis through miRNA 34a-dependent activation of NOTCH. Ann. Rheum. Dis. 79, 507\u2013517 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"683_CR81","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s13075-020-02376-9","volume":"22","author":"CW Wasson","year":"2020","unstructured":"Wasson, C. W. et al. Long non-coding RNA HOTAIR induces GLI2 expression through Notch signalling in systemic sclerosis dermal fibroblasts. Arthritis Res. Ther. 22, 286 (2020).","journal-title":"Arthritis Res. Ther."},{"key":"683_CR82","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.intimp.2019.04.016","volume":"72","author":"X Lin","year":"2019","unstructured":"Lin, X., Li, J. & Xing, Y. Q. Geniposide, a sonic hedgehog signaling inhibitor, inhibits the activation of hepatic stellate cell. Int. Immunopharmacol. 72, 330\u2013338 (2019).","journal-title":"Int. Immunopharmacol."},{"key":"683_CR83","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1165\/rcmb.2016-0268OC","volume":"57","author":"MC Kugler","year":"2017","unstructured":"Kugler, M. C. et al. Sonic hedgehog signaling regulates myofibroblast function during alveolar septum formation in murine postnatal lung. Am. J. Respir. Cell Mol. Biol. 57, 280\u2013293 (2017).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"683_CR84","doi-asserted-by":"publisher","first-page":"4888","DOI":"10.1172\/JCI135439","volume":"130","author":"E Pachera","year":"2020","unstructured":"Pachera, E. et al. Long noncoding RNA H19X is a key mediator of TGF-\u03b2-driven fibrosis. J. Clin. Invest. 130, 4888\u20134905 (2020).","journal-title":"J. Clin. Invest."},{"key":"683_CR85","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.radonc.2014.03.007","volume":"111","author":"HB Forrester","year":"2014","unstructured":"Forrester, H. B., Li, J., Leong, T., McKay, M. J. & Sprung, C. N. Identification of a radiation sensitivity gene expression profile in primary fibroblasts derived from patients who developed radiotherapy-induced fibrosis. Radiother. Oncol. 111, 186\u2013193 (2014).","journal-title":"Radiother. Oncol."},{"key":"683_CR86","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1080\/15592294.2020.1827715","volume":"16","author":"J Henderson","year":"2020","unstructured":"Henderson, J., Wilkinson, S., Przyborski, S., Stratton, R. & O\u2019Reilly, S. microRNA27a-3p mediates reduction of the Wnt antagonist sFRP-1 in systemic sclerosis. Epigenetics 16, 808\u2013817 (2020).","journal-title":"Epigenetics"},{"key":"683_CR87","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1093\/rheumatology\/keaa195","volume":"59","author":"B Yaseen","year":"2020","unstructured":"Yaseen, B. et al. Interleukin-31 promotes pathogenic mechanisms underlying skin and lung fibrosis in scleroderma. Rheumatology 59, 2625\u20132636 (2020).","journal-title":"Rheumatology"},{"key":"683_CR88","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.18632\/aging.202308","volume":"13","author":"Q Yao","year":"2020","unstructured":"Yao, Q. et al. MiR-16-5p suppresses myofibroblast activation in systemic sclerosis by inhibiting NOTCH signaling. Aging 13, 2640\u20132654 (2020).","journal-title":"Aging"},{"key":"683_CR89","first-page":"375","volume":"29","author":"S Feng","year":"2021","unstructured":"Feng, S. & De Carvalho, D. D. Clinical advances in targeting epigenetics for cancer therapy. FEBS J. 29, 375\u2013381 (2021).","journal-title":"FEBS J."},{"key":"683_CR90","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/art.21948","volume":"54","author":"Y Wang","year":"2006","unstructured":"Wang, Y., Fan, P. S. & Kahaleh, B. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts. Arthritis Rheum. 54, 2271\u20132279 (2006).","journal-title":"Arthritis Rheum."},{"key":"683_CR91","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1136\/annrheumdis-2012-203194","volume":"73","author":"C Dees","year":"2014","unstructured":"Dees, C. et al. The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis. Ann. Rheum. Dis. 73, 1232\u20131239 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"683_CR92","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/bjd.12913","volume":"171","author":"YY Wang","year":"2014","unstructured":"Wang, Y. Y. et al. DNA hypermethylation of the forkhead box protein 3 (FOXP3) promoter in CD4+ T cells of patients with systemic sclerosis. Br. J. Dermatol. 171, 39\u201347 (2014).","journal-title":"Br. J. Dermatol."},{"key":"683_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6797","volume":"5","author":"S Noda","year":"2014","unstructured":"Noda, S. et al. Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis. Nat. Commun. 5, 5797 (2014).","journal-title":"Nat. Commun."},{"key":"683_CR94","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1136\/annrheumdis-2017-212265","volume":"77","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. Poly(ADP-ribose) polymerase-1 regulates fibroblast activation in systemic sclerosis. Ann. Rheum. Dis. 77, 744\u2013751 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"683_CR95","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1158\/2159-8290.CD-18-0774","volume":"9","author":"N Daver","year":"2019","unstructured":"Daver, N. et al. Efficacy, safety, and biomarkers of response to azacitidine and nivolumab in relapsed\/refractory acute myeloid leukemia: a nonrandomized, open-label, phase II study. Cancer Discov. 9, 370\u2013383 (2019).","journal-title":"Cancer Discov."},{"key":"683_CR96","doi-asserted-by":"publisher","first-page":"16009","DOI":"10.1038\/celldisc.2016.9","volume":"2","author":"X Xu","year":"2016","unstructured":"Xu, X. et al. A CRISPR-based approach for targeted DNA demethylation. Cell Discov. 2, 16009 (2016).","journal-title":"Cell Discov."},{"key":"683_CR97","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1002\/art.22759","volume":"56","author":"LC Huber","year":"2007","unstructured":"Huber, L. C. et al. Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis. Arthritis Rheum. 56, 2755\u20132764 (2007).","journal-title":"Arthritis Rheum."},{"key":"683_CR98","doi-asserted-by":"publisher","first-page":"ra84","DOI":"10.1126\/scisignal.2004592","volume":"7","author":"S Svegliati","year":"2014","unstructured":"Svegliati, S. et al. Oxidative DNA damage induces the ATM-mediated transcriptional suppression of the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis. Sci. Signal. 7, ra84 (2014).","journal-title":"Sci. Signal."},{"key":"683_CR99","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/nm.3777","volume":"21","author":"K Palumbo-Zerr","year":"2015","unstructured":"Palumbo-Zerr, K. et al. Orphan nuclear receptor NR4A1 regulates transforming growth factor-\u03b2 signaling and fibrosis. Nat. Med. 21, 150\u2013158 (2015).","journal-title":"Nat. Med."},{"key":"683_CR100","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1136\/ard.2011.154211","volume":"71","author":"AM Grabiec","year":"2012","unstructured":"Grabiec, A. M., Korchynskyi, O., Tak, P. P. & Reedquist, K. A. Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay. Ann. Rheum. Dis. 71, 424\u2013431 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"683_CR101","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1002\/art.39061","volume":"67","author":"J Wei","year":"2015","unstructured":"Wei, J. et al. The histone deacetylase sirtuin 1 is reduced in systemic sclerosis and abrogates fibrotic responses by targeting transforming growth factor beta signaling. Arthritis Rheumatol. 67, 1323\u20131334 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"683_CR102","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jdermsci.2017.04.013","volume":"87","author":"X Zhu","year":"2017","unstructured":"Zhu, X. et al. Sirt1 ameliorates systemic sclerosis by targeting the mTOR pathway. J. Dermatol. Sci. 87, 149\u2013158 (2017).","journal-title":"J. Dermatol. Sci."},{"key":"683_CR103","doi-asserted-by":"publisher","first-page":"69321","DOI":"10.18632\/oncotarget.12504","volume":"7","author":"K Akamata","year":"2016","unstructured":"Akamata, K. et al. SIRT3 is attenuated in systemic sclerosis skin and lungs, and its pharmacologic activation mitigates organ fibrosis. Oncotarget 7, 69321\u201369336 (2016).","journal-title":"Oncotarget"},{"key":"683_CR104","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1165\/rcmb.2016-0192OC","volume":"58","author":"H Chu","year":"2018","unstructured":"Chu, H. et al. Sirtuin1 protects against systemic sclerosis-related pulmonary fibrosis by decreasing proinflammatory and profibrotic processes. Am. J. Respir. Cell Mol. Biol. 58, 28\u201339 (2018).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"683_CR105","doi-asserted-by":"publisher","first-page":"L945","DOI":"10.1152\/ajplung.00473.2016","volume":"312","author":"AE Wyman","year":"2017","unstructured":"Wyman, A. E. et al. Sirtuin 7 is decreased in pulmonary fibrosis and regulates the fibrotic phenotype of lung fibroblasts. Am. J. Physiol. Lung Cell Mol. Physiol. 312, L945\u2013L958 (2017).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"683_CR106","first-page":"595","volume":"72","author":"ML Sosulski","year":"2017","unstructured":"Sosulski, M. L., Gongora, R., Feghali-Bostwick, C., Lasky, J. A. & Sanchez, C. G. Sirtuin 3 deregulation promotes pulmonary fibrosis. J. Gerontol. A Biol. Sci. Med. Sci. 72, 595\u2013602 (2017).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"683_CR107","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s43587-021-00027-5","volume":"1","author":"M Rehan","year":"2021","unstructured":"Rehan, M. et al. Restoration of SIRT3 gene expression by airway delivery resolves age-associated persistent lung fibrosis in mice. Nat. Aging 1, 205\u2013217 (2021).","journal-title":"Nat. Aging"},{"key":"683_CR108","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.3892\/ijmm.2020.4748","volume":"46","author":"L Zhu","year":"2020","unstructured":"Zhu, L., Mou, Q., Wang, Y., Zhu, Z. & Cheng, M. Resveratrol contributes to the inhibition of liver fibrosis by inducing autophagy via the microRNA\u201120a\u2011mediated activation of the PTEN\/PI3K\/AKT signaling pathway. Int. J. Mol. Med. 46, 2035\u20132046 (2020).","journal-title":"Int. J. Mol. Med."},{"key":"683_CR109","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1136\/annrheumdis-2017-211501","volume":"77","author":"C Bergmann","year":"2018","unstructured":"Bergmann, C. et al. The histone demethylase Jumonji domain-containing protein 3 (JMJD3) regulates fibroblast activation in systemic sclerosis. Ann. Rheum. Dis. 77, 150\u2013158 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"683_CR110","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jcmgh.2018.09.005","volume":"7","author":"R Martin-Mateos","year":"2019","unstructured":"Martin-Mateos, R. et al. Enhancer of Zeste Homologue 2 inhibition attenuates TGF-\u03b2 dependent hepatic stellate cell activation and liver fibrosis. Cell Mol. Gastroenterol. Hepatol. 7, 197\u2013209 (2019).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"683_CR111","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.127111","volume":"5","author":"G Ligresti","year":"2019","unstructured":"Ligresti, G. et al. CBX5\/G9a\/H3K9me-mediated gene repression is essential to fibroblast activation during lung fibrosis. JCI Insight 5, e127111 (2019).","journal-title":"JCI Insight"},{"key":"683_CR112","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/jid.2012.479","volume":"133","author":"AK Ghosh","year":"2013","unstructured":"Ghosh, A. K. et al. p300 is elevated in systemic sclerosis and its expression is positively regulated by TGF-\u03b2: epigenetic feed-forward amplification of fibrosis. J. Invest. Dermatol. 133, 1302\u20131310 (2013).","journal-title":"J. Invest. Dermatol."},{"key":"683_CR113","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1158\/2159-8290.CD-20-0751","volume":"11","author":"J Welti","year":"2021","unstructured":"Welti, J. et al. Targeting the p300\/CBP axis in lethal prostate cancer. Cancer Discov. 11, 1118\u20131137 (2021).","journal-title":"Cancer Discov."},{"key":"683_CR114","doi-asserted-by":"publisher","DOI":"10.1038\/srep20314","volume":"6","author":"Q Yan","year":"2016","unstructured":"Yan, Q., Chen, J., Li, W., Bao, C. & Fu, Q. Targeting miR-155 to treat experimental scleroderma. Sci. Rep. 6, 20314 (2016).","journal-title":"Sci. Rep."},{"key":"683_CR115","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1517\/14728222.2012.708339","volume":"16","author":"WJ Peng","year":"2012","unstructured":"Peng, W. J. et al. MicroRNA-29: a potential therapeutic target for systemic sclerosis. Expert Opin. Ther. Targets 16, 875\u2013879 (2012).","journal-title":"Expert Opin. Ther. Targets"},{"key":"683_CR116","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.jid.2018.11.007","volume":"139","author":"CL Gallant-Behm","year":"2019","unstructured":"Gallant-Behm, C. L. et al. A microRNA-29 mimic (remlarsen) represses extracellular matrix expression and fibroplasia in the skin. J. Invest. Dermatol. 139, 1073\u20131081 (2019).","journal-title":"J. Invest. Dermatol."},{"key":"683_CR117","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.4049\/jimmunol.1200822","volume":"190","author":"K Makino","year":"2013","unstructured":"Makino, K. et al. The downregulation of microRNA let-7a contributes to the excessive expression of type I collagen in systemic and localized scleroderma. J. Immunol. 190, 3905\u20133915 (2013).","journal-title":"J. Immunol."},{"key":"683_CR118","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nature04303","volume":"438","author":"J Kr\u00fctzfeldt","year":"2005","unstructured":"Kr\u00fctzfeldt, J. et al. Silencing of microRNAs in vivo with \u2018antagomirs\u2019. Nature 438, 685\u2013689 (2005).","journal-title":"Nature"},{"key":"683_CR119","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/annrheumdis-2014-205740","volume":"75","author":"P Zerr","year":"2016","unstructured":"Zerr, P. et al. Sirt1 regulates canonical TGF-\u03b2 signalling to control fibroblast activation and tissue fibrosis. Ann. Rheum. Dis. 75, 226\u2013233 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"683_CR120","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1136\/annrheumdis-2012-201615","volume":"72","author":"M Kramer","year":"2013","unstructured":"Kramer, M. et al. Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis. Ann. Rheum. Dis. 72, 614\u2013620 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"683_CR121","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1136\/gutjnl-2016-311526","volume":"66","author":"T Hardy","year":"2017","unstructured":"Hardy, T. et al. Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease. Gut 66, 1321 (2017).","journal-title":"Gut"},{"key":"683_CR122","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.ebiom.2015.06.025","volume":"2","author":"M Wielscher","year":"2015","unstructured":"Wielscher, M. et al. Diagnostic performance of plasma DNA methylation profiles in lung cancer, pulmonary fibrosis and COPD. EBioMedicine 2, 929\u2013936 (2015).","journal-title":"EBioMedicine"}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41584-021-00683-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-021-00683-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-021-00683-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T12:05:26Z","timestamp":1632312326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-021-00683-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,3]]},"references-count":122,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["683"],"URL":"https:\/\/doi.org\/10.1038\/s41584-021-00683-2","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,3]]},"assertion":[{"value":"6 August 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.O. became a full-time employee of Stipe Therapeutics after submission of this manuscript. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}